Ledger.Open graph →
SEC Form D · Amendment · filed June 26, 2014

Miragen Therapeutics Inc

Offering
$20.0M
Sold
$13.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boulder, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James E. Dickinson · PORTLAND, ORDirectorBryan E. Thurston · PORTLAND, ORDirectorAnish J. Parvatanini · CHICAGO, ILDirectorArjuna J. Ariathurai · CHICAGO, ILExec · DirectorChun E. Liu · PORTLAND, ORDirectorAnthony B. Lennen · Indianapolis, INExec · DirectorKurt H. Martin · Indianapolis, INExecGlen A. Brunk · Indianapolis, INDirectorAmy D. Glover · Indianapolis, INExec · DirectorAndrew D. Corsaro · Indianapolis, INExecS. C. Lottich · Indianapolis, INDirectorPhilip B. Palmer · SAVANNAH, GAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗